| 000 | 01212 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515192637.0 | ||
| 264 | 0 | _c20110614 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1619-7089 | ||
| 024 | 7 |
_a10.1007/s00259-009-1296-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBasu, Sandip | |
| 245 | 0 | 0 |
_aEarly FDG-PET response-adapted risk stratification and further therapeutic decision-making in lymphoma: will this replace the established prognostic indices and be the standard-of-care in clinical management? _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine and molecular imaging _cDec 2009 |
||
| 300 |
_a2089-90 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aDecision Making |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aStandard of Care |
| 650 | 0 | 4 | _aTime Factors |
| 773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 36 _gno. 12 _gp. 2089-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-009-1296-5 _zAvailable from publisher's website |
| 999 |
_c19252129 _d19252129 |
||